INCOMPHARMA ApS

Q: What is the CVR number of INCOMPHARMA ApS?

INCOMPHARMA ApS is registered with CVR / Virk under CVR 33504209.

Q: What is the gross profit of INCOMPHARMA ApS?

INCOMPHARMA ApS reported a gross profit of -DKK 6.0k in 2013.

Q: Where is INCOMPHARMA ApS headquartered?

INCOMPHARMA ApS's registered address is Omøgade 8, 2..

APSDissolved

CVR 33504209Omøgade 8, 2100 København ØEconomic activity was not specified by tax authority· NACE 0000Est. 2011 · 15 years old— employees

Overview

INCOMPHARMA ApS is a Danish APS based in København Ø, operating in the Economic activity was not specified by tax authority sector. Incorporated in 2011, the company reported a gross profit of -DKK 6.0k in its latest annual filing.

Gross profit 2013

-6K DKK

−39% vs 2012

EBITDA margin (of gross profit)

100.0 %

+39% vs 2012

Net profit 2013

-6.1K DKK

0% vs 2012

Key ratios

See full ratios →

89.1 %

Average

Around the average of companies in the same industry

20122013

9.1×

Average

Around the average of companies in the same industry

20122013

-13.3 %

Very weak

Among the 10% lowest rated companies in the industry

20122013

EBITDA — year on year

DKK

Key figures

Annual report 2013

Gross profit	-6K DKK	-39%
EBITDA	-6K DKK	+39%
Net profit	-6.1K DKK	0%
Total assets	45.9K DKK	-6%
Equity	40.9K DKK	-13%
Employees	—	—

Financial development

In its most recent annual report (2013), INCOMPHARMA ApS reported a gross profit of -DKK 6.0k. The figures on this page draw on 2 annual filings covering 2012 to 2013. The bottom line showed a net loss of DKK 6.1k.

At the end of 2013, equity financed 89.1% of the balance sheet, and current assets covered short-term debt 9.1 times.

Financials

Gross profit

DKK

EBITDA

DKK

Income statement

DKK thousands

Item	2013	2012
Gross profit	-6	-10
Staff expenses	-0	-0
EBITDA	-6	-10
Depreciation & amort.	-0	-0
EBIT	-6	-10
Net financials	-0	4
Profit before tax	-6	-6
Tax	-0	-0
Net profit	-6	-6

Get a credit rating – not just the numbers

Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.

See the credit rating

Balance sheet

DKK thousands

Item	2013	2012
Total assets	46	49
Equity	41	47
Long-term debt	0	0
Short-term debt	5	2
Total debt	5	2

Financial ratios

5-year trend

EBITDA margin (of gross profit)

<−999 %

20122013

Equity ratio

89.1 %

Average

Around the average of companies in the same industry

20122013

Return on equity

-14.9 %

Very weak

Among the 10% lowest rated companies in the industry

20122013

Net profit margin (of gross profit)

<−999 %

20122013

Asset turnover (of gross profit)

-0.13×

20122013

Debt / equity

0.12×

Average

Around the average of companies in the same industry

20122013

Sector performance

22 of 28 ratios graded

28 financial ratios from the latest filing, each graded against companies in the same industry.

Profitability

Return on equity (ROE)Very weak

Among the 10% lowest rated companies in the industry

Net profit as a percentage of equity — the return the owners earned on their invested capital this year.

Return on assets (ROA)Very weak

Among the 10% lowest rated companies in the industry

Net profit as a percentage of total assets — the return generated on the capital employed.

Return on net assets (RONA)Very weak

Among the 10% lowest rated companies in the industry

Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.

Basic earning power (BEP)Very weak

Among the 10% lowest rated companies in the industry

EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.

Gross marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.

Operating marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.

Net profit marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The profit for the year as a share of revenue — the company's ability to turn revenue into profit.

Capacity ratioNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.

Liquidity

Current ratioAverage

Around the average of companies in the same industry

Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.

Quick ratioAverage

Around the average of companies in the same industry

Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.

Cash ratioAverage

Around the average of companies in the same industry

Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.

Current assets to equityVery weak

Among the 20% lowest rated companies in the industry

Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.

Fixed assets to long-term capitalVery strong

Among the 10% highest rated companies in the industry

Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.

Cash conversion ratioStrong

Among the 30% highest rated companies in the industry

Cash flow relative to profit — the ability to convert reported profits into accessible cash.

Debt & solvency

Solidity ratioAverage

Around the average of companies in the same industry

Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.

Debt ratioAverage

Around the average of companies in the same industry

Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.

Debt to equityAverage

Around the average of companies in the same industry

Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.

Liabilities to equityAverage

Around the average of companies in the same industry

Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.

Income to debtVery weak

Among the 10% lowest rated companies in the industry

Profit relative to debt — the ability to create earnings while operating with debt.

EBITDA to debtVery weak

Among the 20% lowest rated companies in the industry

EBITDA relative to debt — how much operating earnings are available to service the debt.

Interest coverageVery weak

Among the 20% lowest rated companies in the industry

The ability to pay the interest on the company's debt out of its earnings.

Interest rate on debtWeak

Among the 40% lowest rated companies in the industry

Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.

Interest marginVery weak

Among the 20% lowest rated companies in the industry

The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.

Efficiency & development

Equity to contributed capitalVery weak

Among the 20% lowest rated companies in the industry

Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.

One-year change in equityVery weak

Among the 20% lowest rated companies in the industry

The size of this year's increase or decrease in the company's equity.

One-year change in debtVery weak

Among the 20% lowest rated companies in the industry

The size of this year's increase or decrease in the company's debt.

Asset turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to total assets — the ability to generate revenue from the asset base.

Inventory turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.

Annual reports & filings

Annual report 2013
Filed via CVR / Virk · Period 2012-04-01 – 2013-03-31
View PDF
Annual report 2012
Filed via CVR / Virk · Period 2011-02-23 – 2012-03-31
View PDF

People & ownership

Management

Actively employed in the business

Name	Role	Member since

Former (2)


IZ Ivan Zammit Management	Management	2011 – 2014
LR Larysa Romanova Management	Management	2011 – 2012

Board of directors

Non-executive oversight

No data on file.

Shareholders

Active legal owners

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.

One in three Danish companies experiences fraud

Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.

See the fraud module

Related companies

Company hierarchy

No registered parent or subsidiaries

Board network connections

Board members of INCOMPHARMA ApS hold no positions in other companies.

Frequently asked questions

What is the CVR number of INCOMPHARMA ApS?

INCOMPHARMA ApS is registered with CVR / Virk under CVR 33504209.

What is the gross profit of INCOMPHARMA ApS?

INCOMPHARMA ApS reported a gross profit of -DKK 6.0k in 2013.

Where is INCOMPHARMA ApS headquartered?

INCOMPHARMA ApS's registered address is Omøgade 8, 2..